Translation
	February 4, 2009
	Name of listed company:   Chugai Pharmaceutical Co., Ltd. Code number: 4519 (1st Section of Tokyo Stock Exchange) Head office: 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo President & CEO: Osamu Nagayama Inquiries to: Mamoru Togashi, General Manager, Corporate Communications Dept.   Tel:+81-(0)3-3273-0881

F. Hoffmann-La Roche Announces Financial Results for Fiscal 2008

F. Hoffmann-La Roche Ltd. (hereafter "Roche") [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced today, its financial results for fiscal 2008 (January 1 - December 31, 2008). Roche owns 59.9% of Chugai's outstanding shares (61.5% of voting rights) as of end of December 2008. Its press release and presentation materials can be found on its Website (http://www.roche.com).

Chugai's sales for the period of January 1 to December 31, 2008 are included in the announced Roche Group's sales. These results are based on Roche's accounting policies which conform to International Financial Reporting Standards, which differ from generally accepted accounting standards in Japan.